Webinar On-Demand: A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing
Fecal calprotectin is a clinical test used as an aid in the differentiation of Inflammatory Bowel Disease (IBD) from irritable bowel syndrome (IBS) and therapeutic monitoring in patients with inflammatory bowel disease (IBD). Over the years, numerous improvements have been made to fecal calprotectin assays, including development of more automated immunoassays and simple-to-use extraction devices. In this webinar, we will discuss how to validate and launch a FDA-approved assay. This will include a discussion of available platforms and tips for successful implementation of fecal calprotectin testing. We will also discuss the benefits of brining the testing in-house, which include reduced costs and improved turn-around-times.
Presenter: Dr. Heather Nelson, University of Utah School of Medicine, Department of Pathology
Dr. Heather Nelson is a medical director of clinical chemistry at ARUP Laboratories and an assistant professor (clinical) in the Department of Pathology at the University of Utah School of Medicine. She specializes in esoteric testing that includes non-infectious gastrointestinal assays, advanced lipid analyses, neuroendocrine tumor markers, and maternal serum screening. Dr. Nelson received her doctorate degree in cell and developmental biology from SUNY Upstate Medical University. She then completed a post-doctoral research fellowship in diabetes, endocrinology, and metabolism at Vanderbilt University Medical Center followed by her clinical chemistry fellowship training at the University of Utah.
